Dr. Shelby(@shelbynewsad):small molecule synthesis is stuck decades behind other modalities @satomic_ai is making it more engineerable to enable abundance and eventually abstraction. despite small molecule engineering difficulties, they still are 50% of drug approvals and could be more when Satomic increases the scale and speed of synthesis.

Dr. Shelby

@shelbynewsad

“the only VC still keeping biotech weird”. partner @compoundVC | writing

加入 October 2014

3.2K 正在關注 6.2K 粉絲

Dr. Shelby@shelbynewsad

2026.08.24 14:47

small molecule synthesis is stuck decades behind other modalities @satomic_ai is making it more engineerable to enable abundance and eventually abstraction. despite small molecule engineering difficulties, they still are 50% of drug approvals and could be more when Satomic increases the scale and speed of synthesis.